ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 780

$1.16M Total Retail Price of All Prescriptions

Rank: 39 out of 780

624 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 20,822 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
GABAPENTIN 946 767 1 13
HYDROCODONE-ACETAMINOPHEN 929 674 S3 2 1
CITALOPRAM HBR 764 601 3 23
LEVOTHYROXINE SODIUM 715 597 4 5
METOPROLOL SUCCINATE 623 585 5 20
OMEPRAZOLE 525 431 6 3
TORSEMIDE 525 443 10 6 114
FUROSEMIDE 464 351 8 7
SIMVASTATIN 431 386 9 2
DONEPEZIL HCL 422 396 10 31
PRAVASTATIN SODIUM 415 371 11 9
QUETIAPINE FUMARATE 403 370 12 81
POTASSIUM CHLORIDE 402 327 13 11
LOSARTAN POTASSIUM 372 354 14 18
NAMENDA 359 344 15 46
PREDNISONE 352 308 16 40
LISINOPRIL 346 296 17 6
METOPROLOL TARTRATE 342 304 18 19
TRAZODONE HCL 304 208 19 35
DICLOFENAC SODIUM 296 240 20 137
HYDROCHLOROTHIAZIDE 291 266 21 10
MIRTAZAPINE 286 270 22 58
AMLODIPINE BESYLATE 281 246 23 4
GLIMEPIRIDE 266 239 24 30
PANTOPRAZOLE SODIUM 256 208 25 25
CARVEDILOL 254 226 26 14
ESCITALOPRAM OXALATE 252 212 27 61
ZOLPIDEM TARTRATE 248 146 28 17
MELOXICAM 246 221 29 16
FELODIPINE ER 229 207 30 126
RISPERIDONE 216 208 31 98
WARFARIN SODIUM 213 185 32 24
TRAMADOL HCL 211 145 33 15
LOSARTAN-HYDROCHLOROTHIAZIDE 207 189 34 33
POLYETHYLENE GLYCOL 3350 202 202 35 79
TAMSULOSIN HCL 196 166 36 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 184 155 37 26
TRAMADOL HCL-ACETAMINOPHEN 172 138 38 140
AMLODIPINE BESYLATE-BENAZEPRIL 167 136 39 50
DIVALPROEX SODIUM 156 111 40 119
SERTRALINE HCL 151 143 41 27
METFORMIN HCL 150 121 42 8
SEROQUEL 147 138 43 172
BENAZEPRIL HCL 141 114 44 59
AZITHROMYCIN 139 112 45 38
ALLOPURINOL 138 124 46 29
CYMBALTA 138 75 46 51
PROMETHAZINE HCL 135 73 R 48 66
ATORVASTATIN CALCIUM 134 128 49 12
LEVETIRACETAM 130 103 50 130
METFORMIN HCL ER 126 120 51 43
NADOLOL 126 49 51 253
LYRICA 122 67 53 52
VENLAFAXINE HCL ER 121 78 54 117
BUMETANIDE 117 109 55 96
RANITIDINE HCL 115 77 56 39
EXELON 112 112 57 132
CLOPIDOGREL 108 90 58 34
GLIPIZIDE 108 72 58 74
SPIRONOLACTONE 106 77 60 53
CLONIDINE HCL 104 82 61 28
KLOR-CON M10 104 97 61 168
ROPINIROLE HCL 95 71 63 87
PROPRANOLOL HCL 91 91 64 133
KLOR-CON 10 90 90 65 90
ATENOLOL 89 65 66 21
NEXIUM 87 58 67 22
TRIAMCINOLONE ACETONIDE 83 48 68 154
CIPROFLOXACIN HCL 83 67 68 49
FLUTICASONE PROPIONATE 82 74 70 41
TRIAMTERENE-HCTZ 82 76 70 37
LAMOTRIGINE 82 32 70 205
CARISOPRODOL 79 42 R 73 67
TOPIRAMATE 78 35 74 145
FOSINOPRIL SODIUM 78 77 74 112
VENTOLIN HFA 78 61 74 91
IPRATROPIUM-ALBUTEROL 77 77 77 214
IBUPROFEN 76 56 78 93
FLUCONAZOLE 74 54 79 111
PLAVIX 74 65 79 45
ENALAPRIL MALEATE 73 73 81 64
LEVEMIR 72 46 82 198
ALBUTEROL SULFATE 72 71 82 163
MUPIROCIN 70 65 84 173
RAMIPRIL 69 69 85 70
KLOR-CON M20 69 48 85 57
BUSPIRONE HCL 68 65 87 125
SUCRALFATE 68 56 87 149
AMPHETAMINE SALT COMBO 66 27 S2 89 201
CARBIDOPA-LEVODOPA 65 65 90 124
NUEDEXTA 65 55 90 356
OLANZAPINE 61 32 92 191
JANUVIA 61 45 92 85
LANTUS 59 47 94 71
IMIPRAMINE HCL 59 57 R 94 310
FAMOTIDINE 59 59 94 86
CLONAZEPAM 58 48 97 422
ESTRADIOL 57 43 R 98 122
COLESTIPOL HCL 57 47 98 273
AMITRIPTYLINE HCL 56 54 R 100 48
AMIODARONE HCL 56 53 100 139
TIZANIDINE HCL 56 24 100 82
ENABLEX 56 44 100 260
HUMULIN R 55 46 104 228
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 50 105 88
JANUMET 54 54 105 208
DETROL LA 54 49 105 215
LACTULOSE 53 42 108 178
LEXAPRO 52 45 109 219
METOLAZONE 51 46 110 195
PHENYTOIN SODIUM EXTENDED 51 39 110 128
PRIMIDONE 50 38 112 199
BYSTOLIC 50 46 112 118
PREMARIN 50 50 R 112 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.